Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201

Published:2024-04 Issue: Volume:190 Page:107509
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chul Cho Byoung,Han Ji-Youn,Hyeong Lee Ki,Lee Yun-Gyoo,Kim Dong-Wan,Joo Min Young,Kim Sang-We,Kyung Cho Eun,Kim Joo-Hang^ORCID,Lee Gyeong-Won,Sook Lee Sung,Lee NaMi,Young Wang Jang,Park Hyejoo^ORCID,Ahn Myung-Ju^ORCID

Funder

Yuhan

Publisher

Elsevier BV

Reference30 articles.

1. Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a “tail plateau” in the survival curve of these patients?;Shimamura;BMC Cancer,2022

2. Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs;Lin;J. Thorac. Oncol.,2016

3. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER);Shi;J. Thorac. Oncol.,2014

4. Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function;Kitadai;Analysis,2022

5. Overview of current systemic management of EGFR-mutant NSCLC;Hsu;Ann. Oncol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP